"...M&A, restructuring, capital raising and leading the finance function..."
Take your pick. What is his appointment for? I don't think capital raising is in consideration here as IMU is already very well capitalised. So that left M&A, restructuring and finance function. Given the stage that IMU is at, chances of M&A is rather high, I reckon.
Ann: Imugene appoints experienced life sciences CFO Mike Tonroe, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $80.77M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.0¢ | 27.0¢ | $461.4K | 1.681M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 134437 | 7 |
View Market Depth
| Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
| IMU (ASX) Chart |